A detailed history of Maltin Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Maltin Wealth Management, Inc. holds 1,523 shares of ABBV stock, worth $259,443. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,523
Previous 1,517 0.4%
Holding current value
$259,443
Previous $260,000 15.38%
% of portfolio
0.16%
Previous 0.16%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $983 - $1,195
6 Added 0.4%
1,523 $300,000
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $12,383 - $14,460
-80 Reduced 5.01%
1,517 $260,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $958 - $1,092
6 Added 0.38%
1,597 $290,000
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $1,100 - $1,239
8 Added 0.51%
1,591 $246,000
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $80,955 - $93,717
-606 Reduced 27.68%
1,583 $235,000
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $17,756 - $22,096
134 Added 6.52%
2,189 $294,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $128,402 - $159,788
-969 Reduced 32.04%
2,055 $276,000
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $3,036 - $3,497
21 Added 0.7%
3,024 $481,000
Q4 2022

Feb 16, 2023

SELL
$138.31 - $165.87 $44,535 - $53,410
-322 Reduced 9.68%
3,003 $485,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $3,086 - $3,540
23 Added 0.7%
3,325 $446,000
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $5,780 - $7,348
-42 Reduced 1.26%
3,302 $506,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $382,610 - $474,711
-2,899 Reduced 46.44%
3,344 $542,000
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $5,586 - $7,068
52 Added 0.84%
6,243 $845,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $658,722 - $747,748
6,191 New
6,191 $668,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $180,239 - $211,541
-2,098 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $153,930 - $205,981
2,098 New
2,098 $206,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Maltin Wealth Management, Inc. Portfolio

Follow Maltin Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maltin Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maltin Wealth Management, Inc. with notifications on news.